CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

Clinical trial NCT04881838 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04881838
Sponsor: Children's Cancer Group, China
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pediatric Anaplastic Large Cell Lymphoma

Start date: 2021-03-01
Primary completion: 2026-03-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.